Ocugen (OCGN) Cash from Operations (2014 - 2026)
Ocugen (OCGN) reported Cash from Operations of 21794000.0 for Q1 2026, down 12.59% on a YoY basis from 24933005.79 in Q1 2025, and down 56.11% quarter-over-quarter from 13961000.0 in Q4 2025.
Ocugen (OCGN) Cash from Operations (2014 - 2026) Analysis & Trends
Ocugen has reported Cash from Operations for 13 years, with the latest figure at 21794000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 12.59% year-over-year to 21794000.0; the trailing twelve-month figure through Mar 2026 stood at 59401000.0 (down 16.69% YoY), and the FY2025 full-year result was 56964000.0, down 35.17% from the prior year.
- Cash from Operations for Q1 2026 stood at 21794000.0, down from 13961000.0 in the prior quarter.
- The five-year high for Cash from Operations was 9911000.0 in Q2 2024, with the low at 21794000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 14296058.82 across 5 years, with a median of 13797000.0 in 2022.
- Annual changes were most pronounced in 2022 — Cash from Operations sank 185.18% — and 2024, when it surged 47.3%.
- Ocugen's Cash from Operations stood at 16914000.0 in 2022, then jumped by 33.18% to 11302000.0 in 2023, then increased by 8.3% to 10364000.0 in 2024, then tumbled by 34.71% to 13961000.0 in 2025, then slumped by 56.11% to 21794000.0 in 2026.
- The last three Cash from Operations figures came in at 21794000.0 (Q1 2026), 13961000.0 (Q4 2025), and 12916000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ocugen | 411.07 Mn | 411.07 Mn | - | -21.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.79 Mn |
| Mar 31, 2026 | -21.79 Mn |
| Dec 31, 2025 | -13.96 Mn |
| Dec 31, 2025 | -13.96 Mn |
| Sep 30, 2025 | -12.92 Mn |
| Sep 30, 2025 | -12.92 Mn |
| Jun 30, 2025 | -10.73 Mn |
| Jun 30, 2025 | -10.73 Mn |
| Mar 31, 2025 | -19.36 Mn |
| Mar 31, 2025 | -19.36 Mn |
| Dec 31, 2024 | -10.36 Mn |
| Dec 31, 2024 | -10.36 Mn |
| Sep 30, 2024 | -11.27 Mn |
| Sep 30, 2024 | -11.27 Mn |
| Jun 30, 2024 | -9.91 Mn |
| Jun 30, 2024 | -9.91 Mn |
| Mar 31, 2024 | -10.60 Mn |
| Mar 31, 2024 | -10.60 Mn |
| Dec 31, 2023 | -11.30 Mn |
| Dec 31, 2023 | -11.30 Mn |